Atlas Trials

The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer

Clinical trial NCT02733107 · UNKNOWN

Trial details

NCT number
NCT02733107
Sponsor
Third Military Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2016-03-01
Primary completion
2019-12-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.